United maintain positive outlook

United Drug has revealed today in its interim management statement (IMS) that during the first quarter of 2008, the group continued to experience good trading conditions in each of its four business divisions and overall group performance is well ahead of the corresponding period in the prior year, in line with expectations.

During the period under review, the group continued its expansion as an international healthcare services company with bolt-on acquisitions in the UK and US markets.

The group remains positive about the fundamentals of core markets and its position within those markets.

United Drug will hold its Annual General Meeting of shareholders on Tuesday February 26 and will announce its first half results, for the six months to March 31 2008, on Wednesday May 7 2008.